Delivery Order SPE2DR25D2104-SPE2DR26F3SKA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,911.46 to AmerisourceBergen Drug Corp for the supply of Rexulti (brexpiprazole) 1 mg tablets in a 30-count package. This competitively awarded, firm fixed-price contract with no set-aside designation was issued on December 9, 2025, with an ultimate completion date of December 10, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,723.01 to AmerisourceBergen Drug Corp for the supply of Rexulti (brexpiprazole) 2 mg tablets in a 30-count package. The contract is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and was competitively awarded without set-aside designation. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,195.59 by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Rexulti 2 mg tablets (30-count packages). The contract carries a firm fixed price structure with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by September 10, 2025, with performance conducted from the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Rexulti (brexpiprazole) 0.25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $9,337.68 and an ultimate completion date of November 17, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $15,368.07 to AmerisourceBergen Drug Corp for Rexulti 1 mg tablets (30-count units) on August 18, 2025, with completion targeted for August 19, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is an atypical antipsychotic medication used in the treatment of psychiatric...
- The Defense Logistics Agency awarded a delivery order valued at $5,066.14 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count package) on November 14, 2025. This firm fixed-price delivery order, which is part of a larger competitively awarded contract vehicle, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with completion targeted for November 17, 2025. The contract includes no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a delivery order valued at $8,064.96 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count packaging) on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $23,642.73 to AmerisourceBergen Drug Corp for Rexulti 2 mg tablets (30-count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is a prescription antipsychotic medication used in treating major...
- The Defense Logistics Agency awarded a delivery order valued at $11,740.62 to AmerisourceBergen Drug Corp for the supply of Rexulti (brexpiprazole) 1 mg tablets in a 30-count package. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of October 31, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rexulti 1 mg tablets (30-count) valued at $5,894.80 under a firm fixed-price contract, with performance through August 21, 2025. This non-set-aside award was issued on August 20, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is an atypical antipsychotic medication used in treating schizophrenia and major depressive disorder, reflecting DLA's...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3SKADelivery Order
The Defense Logistics Agency awarded a $2,002.05 delivery order to AmerisourceBergen Drug Corp for Rexulti (brexpiprazole) 3 mg tablets in a 30-count package. This is a firm fixed price, competitively awarded order with no set-aside designation, with an ultimate completion date of December 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare programs globally. Rexulti, an atypical antipsychotic medication, is a brand-name pharmaceutical product that supports the medical supply chain requirements for the Department of Defense and related federal healthcare systems. AmerisourceBergen's performance under this and similar delivery orders demonstrates its capability to meet federal procurement requirements for specialized pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/28/25 |